Medicover revenue and financials
kr 260.00Change from previous close: +0.19%Absolute change: +kr 0.50
In the fiscal year ended December 2025, Medicover reported revenue of €2.38B (+13.69% year over year). Net income was €77.5M, a net margin of 3.3%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +13.69%
- 2025 vs 2024
- Net income growth
- +364.07%
- 2025 vs 2024
- Net margin
- 3.3%
- 2024: 0.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total revenue | 640 | 624 | 612 | 597 | 578 |
| Cost of revenue | 487 | 477 | 475 | 455 | 445 |
| Gross profit | 154 | 147 | 137 | 142 | 133 |
| Selling, general and administrative | 103 | 101 | 102 | 100 | 96.7 |
| Operating income | 51.2 | 46.7 | 35.2 | 41.7 | 36.0 |
| EBIT | 49.8 | 45.2 | 37.5 | 41.5 | 41.3 |
| EBITDA | 105 | 99.7 | 92.4 | 96.0 | 91.8 |
| Interest expense | 16.6 | 16.6 | 16.0 | 16.5 | 15.2 |
| Pre-tax income | 33.2 | 28.6 | 21.5 | 25.0 | 26.1 |
| Income tax | 9.3 | 8.0 | 4.2 | 7.0 | 7.3 |
| Net income | 24.5 | 22.1 | 18.8 | 19.1 | 20.1 |
| Net income to common shareholders | 24.5 | 22.1 | 18.8 | 19.1 | 20.1 |
| Basic EPS | 0.16 | 0.15 | 0.12 | 0.13 | 0.13 |
| Diluted EPS | 0.16 | 0.15 | 0.12 | 0.13 | 0.13 |
| Average shares (basic) | 152 | 151 | 151 | 151 | 150 |
| Average shares (diluted) | 152 | 152 | 151 | 151 | 151 |